{"abstract":"This is notice, in accordance with 35 U.S.C. 209 and 37 CFR part 404, that the National Institutes of Health (NIH), Department of Health and Human Services, is contemplating the grant of an exclusive worldwide license to practice the inventions embodied in:","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2013/07/16/2013-16949.html","cfr_references":[],"citation":"78 FR 42530","comment_url":null,"comments_close_on":"2013-08-15","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license that are received by the NIH Office of Technology Transfer on or before August 15, 2013 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2013-16949","effective_on":null,"end_page":42531,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2013/07/16/2013-16949.xml","html_url":"https://www.federalregister.gov/documents/2013/07/16/2013-16949/prospective-grant-of-an-exclusive-license-human-papillomavirus-16-e2-and-e6-peptides-for-cervical","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2013-16949?publication_date=2013-07-16","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2013-07-16/2013-16949/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":83,"last_updated":"2026-08-25 06:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2013-07-16/pdf/2013-16949.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2013-16949.pdf?1373892642","publication_date":"2013-07-16","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2013/07/16/2013-16949.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=NIH_FRDOC_0001","supporting_documents_count":0,"docket_id":"NIH_FRDOC_0001","regulation_id_number":null,"title":"Recently Posted NIH Rules and Notices.","checked_regulationsdotgov_at":"2013-08-17T05:00:11Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":42530,"subtype":null,"title":"Prospective Grant of an Exclusive License: Human Papillomavirus 16 E2 and E6 Peptides for Cervical Cancer Vaccine Development","toc_doc":"Human Papillomavirus 16 E2 and E6 Peptides for Cervical Cancer Vaccine Development","toc_subject":"Prospective Grants of Exclusive Licenses:","topics":[],"type":"Notice","volume":78}